HIV Antiviral Expanded for Use in Very Young Children

The FDA expanded use of the HIV antiviral dolutegravir to treat children aged 4 weeks or older who weigh at least 3 kg. The drug was previously approved for children aged 6 years or older who weighed at least 30 kg.
Source: JAMA - Category: General Medicine Source Type: research